Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil E Kay

Showing results (21-30 of 325) with videos related to

Pageof 33
Sort By:
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Update on monoclonal antibody therapy in chronic lymphocytic leukemiaClive S Zent, Neil E Kay
Blood|November 22, 2019
B-cell prolymphocytic leukemia has 3 subsetsNeil E Kay, Curtis A Hanson
Seminars in Oncology|April 18, 2006
The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemiaTait D Shanafelt, Neil E Kay
Current Oncology Reports|August 21, 2007
Chronic lymphocytic leukemia: biology and current treatmentClive S Zent, Neil E Kay
Hematology. American Society of Hematology. Education Program|November 21, 2007
Comprehensive management of the CLL patient: a holistic approachTait D Shanafelt, Neil E Kay
Clinical Lymphoma & Myeloma|September 26, 2009
Familial chronic lymphocytic leukemia: what does it mean to me?Susan L Slager, Neil E Kay
Methods in Molecular Biology (Clifton, N.J.)|February 16, 2013
CGH protocols: chronic lymphocytic leukemiaEsteban Braggio, Rafael Fonseca, Neil E Kay
Clinical Advances in Hematology & Oncology : H&O|February 17, 2021
Early intervention in asymptomatic chronic lymphocytic leukemiaEli Muchtar, Neil E Kay, Sameer A Parikh
Leukemia Research|January 15, 2008
Controversies in the front-line management of chronic lymphocytic leukemiaChadi Nabhan, Tait D Shanafelt, Neil E Kay
Clinical Advances in Hematology & Oncology : H&O|December 14, 2018
Immune-mediated hemolytic anemia and thrombocytopenia in clonal B-cell disorders: a reviewUrshila Durani, Ronald S Go, Neil E Kay
Pageof 33

Showing results (21-30 of 325) with videos related to

Sort By:
Pageof 33
Clinical Advances in Hematology & Oncology : H&O|September 16, 2005
Update on monoclonal antibody therapy in chronic lymphocytic leukemiaClive S Zent, Neil E Kay
Blood|November 22, 2019
B-cell prolymphocytic leukemia has 3 subsetsNeil E Kay, Curtis A Hanson
Seminars in Oncology|April 18, 2006
The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemiaTait D Shanafelt, Neil E Kay
Current Oncology Reports|August 21, 2007
Chronic lymphocytic leukemia: biology and current treatmentClive S Zent, Neil E Kay
Hematology. American Society of Hematology. Education Program|November 21, 2007
Comprehensive management of the CLL patient: a holistic approachTait D Shanafelt, Neil E Kay
Clinical Lymphoma & Myeloma|September 26, 2009
Familial chronic lymphocytic leukemia: what does it mean to me?Susan L Slager, Neil E Kay
Methods in Molecular Biology (Clifton, N.J.)|February 16, 2013
CGH protocols: chronic lymphocytic leukemiaEsteban Braggio, Rafael Fonseca, Neil E Kay
Clinical Advances in Hematology & Oncology : H&O|February 17, 2021
Early intervention in asymptomatic chronic lymphocytic leukemiaEli Muchtar, Neil E Kay, Sameer A Parikh
Leukemia Research|January 15, 2008
Controversies in the front-line management of chronic lymphocytic leukemiaChadi Nabhan, Tait D Shanafelt, Neil E Kay
Clinical Advances in Hematology & Oncology : H&O|December 14, 2018
Immune-mediated hemolytic anemia and thrombocytopenia in clonal B-cell disorders: a reviewUrshila Durani, Ronald S Go, Neil E Kay
Pageof 33